Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 22 May 24 424B3 Prospectus supplement
- 8 Apr 24 EFFECT Notice of effectiveness
- 5 Apr 24 POS AM Prospectus update (post-effective amendment)
- 1 Apr 24 POS AM Prospectus update (post-effective amendment)
- 2 Sep 22 424B4 Prospectus supplement with pricing info
- 30 Aug 22 EFFECT Notice of effectiveness
- 18 Aug 22 S-1/A IPO registration (amended)
-
4 Aug 22 S-1/A IPO registration (amended)
- 2 Aug 22 S-1/A IPO registration (amended)
- 27 Jul 22 S-1/A IPO registration (amended)
- 16 Jun 22 S-1/A IPO registration (amended)
- 25 May 22 FWP Free writing prospectus
- 25 May 22 S-1/A IPO registration (amended)
- 25 Apr 22 S-1 IPO registration
BIAF similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 5 to Form S-1 of our report dated April 22, 2022 except as to Note 16, as to which the date is June 23, 2022, relating to the financial statements of bioAffinity Technologies, Inc., which is contained in that Prospectus. We also consent the reference to our Firm under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
New York, New York
August 4, 2022